九洲药业(603456)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

603456 九洲药业

午间休市 07-30 11:29:41

{"stockData":{"symbol":"603456","market":"SH","secType":"STK","nameCN":"九洲药业","latestPrice":13.42,"timestamp":1722310181000,"preClose":13.33,"halted":0,"volume":6167697,"delay":0,"floatShares":898000000,"shares":899000000,"eps":1.1,"marketStatus":"午间休市","marketStatusCode":3,"change":0.09,"latestTime":"07-30 11:29:41","open":13.32,"high":13.7,"low":13.29,"amount":83369200,"amplitude":0.0308,"askPrice":13.42,"askSize":37,"bidPrice":13.41,"bidSize":183,"shortable":0,"etf":0,"ttmEps":1.1,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1722315600000},"adr":0,"adjPreClose":13.33,"symbolType":"stock","openAndCloseTimeList":[[1722303000000,1722310200000],[1722315600000,1722322800000]],"highLimit":14.66,"lowLimit":12,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":899435228,"pbRate":1.38,"roa":"--","roe":"2.77%","epsLYR":1.16,"committee":0.737098,"marketValue":12070000000,"floatMarketCap":12053000000,"peRate":12.2,"changeRate":0.0068,"turnoverRate":0.0069,"status":0},"requestUrl":"/m/hq/s/603456","defaultTab":"news","newsList":[{"id":"2454609248","title":"九洲药业7月23日获融资净买入399万元 环比增加730.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454609248","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454609248?lang=zh_cn&edition=full","pubTime":"2024-07-25 10:00","pubTimestamp":1721872811,"startTime":"0","endTime":"0","summary":"7月23日，九洲药业获融资净买入399万元，环比上一交易日增加730.70%。其中，融资买入1214万元，融资偿还815万元。融券方面，融券卖出0.15万股，当前融券余量为41.39万股。A股市场共有3350股获融资净买入，九洲药业净买入额排名第329。股市有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407251002089ee80852&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407251002089ee80852&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603456","BK0070"],"gpt_icon":0},{"id":"2454906864","title":"北向资金7月24日净卖出九洲药业6.48万股 连续5日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2454906864","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454906864?lang=zh_cn&edition=full","pubTime":"2024-07-25 09:30","pubTimestamp":1721871030,"startTime":"0","endTime":"0","summary":"7月24日，北向资金减持九洲药业6.48万股连续5日减持。截止当日收盘，沪股通共持有九洲药业901.55万股，占流通股1.00%。沪股通减持金额前五个股分别为贵州茅台、伊利股份、长江电力、中国建筑、工商银行。九洲药业近5个交易日下跌4.05%，沪股通累计减持113.59万股；近20个交易日下跌7.53%，沪股通累计增持198.80万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407250934139ee7f1ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407250934139ee7f1ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0029","000159","BK0250","BK0025","603456","BK0028","BK0019","BK0070","BK0239","BK0077"],"gpt_icon":0},{"id":"2453403501","title":"九洲药业：7月22日高管沙裕杰增持股份合计5.23万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2453403501","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453403501?lang=zh_cn&edition=full","pubTime":"2024-07-23 20:01","pubTimestamp":1721736087,"startTime":"0","endTime":"0","summary":"证券之星消息，根据7月23日市场公开信息、上市公司公告及交易所披露数据整理，九洲药业最新董监高及相关人员股份变动情况：2024年7月22日公司董事,高级管理人员沙裕杰共增持公司股份5.23万股，占公司总股本为0.0058%。九洲药业近半年内的董监高及核心技术人员增减持详情如下：九洲药业的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流出2008.38万，融资余额减少；融券净流出9.21万，融券余额减少。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072300039077.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603456","BK0070"],"gpt_icon":0},{"id":"2453104033","title":"九洲药业：董事兼总裁梅义将增持约64万股，董事、副总裁沙裕杰增持约19万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2453104033","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453104033?lang=zh_cn&edition=full","pubTime":"2024-07-23 19:41","pubTimestamp":1721734861,"startTime":"0","endTime":"0","summary":"每经AI快讯，九洲药业7月23日晚间发布公告称，截至公告披露日，董事兼总裁梅义将先生累计增持公司股份约64万股，占公司总股本的0.0715%，增持金额1205万元；董事、副总裁兼财务负责人沙裕杰先生累计增持公司股份约19万股，占公司总股本的0.0211%，增持金额302万元。相关增持计划实施完毕。2023年1至12月份，九洲药业的营业收入构成为：化学原料药及中间体的生产及销售占比97.87%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407231941219ee2765b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407231941219ee2765b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603456","BK0070"],"gpt_icon":0},{"id":"2453108350","title":"九洲药业(603456.SH)两名董事高管合计增持83.27万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2453108350","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453108350?lang=zh_cn&edition=full","pubTime":"2024-07-23 17:06","pubTimestamp":1721725595,"startTime":"0","endTime":"0","summary":"九洲药业(603456.SH)发布公告，截至公告披露日，董事兼总裁梅义将先生累计增...","market":"us","thumbnail":"https://img.zhitongcaijing.com/astock/4.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/4.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1154443.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0070","BK0239","603456"],"gpt_icon":0},{"id":"2453701784","title":"九洲药业07月23日遭主力抛售660万元 环比增加133.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453701784","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453701784?lang=zh_cn&edition=full","pubTime":"2024-07-23 15:18","pubTimestamp":1721719097,"startTime":"0","endTime":"0","summary":"07月23日, 九洲药业股价跌3.13%，报收13.31元，成交金额1.05亿元，换手率0.87%，振幅3.06%，量比1.02。九洲药业今日主力资金净流出660万元，连续3日净流出，上一交易日主力净流出283万元，今日环比增加133.22%。该股近5个交易日下跌0.15%，主力资金累计净流出1828万元，其中3个交易日为股价上涨时净流出；近20日主力资金累计净流出4376万元，其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407231527259ee1b0d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407231527259ee1b0d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603456","BK0239","BK0070"],"gpt_icon":0},{"id":"2453472467","title":"北向资金7月22日净卖出九洲药业17.11万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2453472467","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453472467?lang=zh_cn&edition=full","pubTime":"2024-07-23 09:30","pubTimestamp":1721698233,"startTime":"0","endTime":"0","summary":"7月22日，北向资金减持九洲药业17.11万股连续3日减持。截止当日收盘，沪股通共持有九洲药业945.50万股，占流通股1.05%。沪股通减持金额前五个股分别为中信证券、万华化学、金山办公、中天科技、斯达半导。九洲药业近5个交易日上涨3.39%，沪股通累计减持44.19万股；近20个交易日下跌0.43%，沪股通累计增持213.43万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072309344695514dcc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072309344695514dcc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603456","BK0070","BK0239"],"gpt_icon":0},{"id":"2453761173","title":"九洲药业：7月19日高管沙裕杰增持股份合计10000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2453761173","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453761173?lang=zh_cn&edition=full","pubTime":"2024-07-22 20:01","pubTimestamp":1721649679,"startTime":"0","endTime":"0","summary":"证券之星消息，根据7月22日市场公开信息、上市公司公告及交易所披露数据整理，九洲药业最新董监高及相关人员股份变动情况：2024年7月19日公司董事,高级管理人员沙裕杰共增持公司股份1.0万股，占公司总股本为0.0011%。九洲药业近半年内的董监高及核心技术人员增减持详情如下：九洲药业的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流出2984.47万，融资余额减少；融券净流出6.66万，融券余额减少。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072200028866.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603456","BK0070","BK0239"],"gpt_icon":0},{"id":"2452423260","title":"中欧医疗健康股票仓位升至三年最高 葛兰二季度十大重仓股出炉","url":"https://stock-news.laohu8.com/highlight/detail?id=2452423260","media":"澎湃新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452423260?lang=zh_cn&edition=full","pubTime":"2024-07-19 17:12","pubTimestamp":1721380320,"startTime":"0","endTime":"0","summary":"　　中欧医疗健康股票仓位升至三年最高水平！7月19日，中欧基金葛兰在管的3只公募基金披露2024年二季报，其持仓情况也随之浮出水面。　　截至2024年二季度末，葛兰在管公募基金规模约为407.65亿元，相较于一季度末时的458.74亿元，下降11.14%。　　股票仓位方面，葛兰在2024年二季度小幅度提升了中欧医疗健康的股票仓位，由原本的92.79%升至93.73%，这已是该基金三年来最高水平；另外2只基金的股票仓位则小幅度下降。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-07-19/doc-inceshny5448585.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-07-19/doc-inceshny5448585.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0320764599.SGD","BK0171","IE00B543WZ88.USD","603259","300760","09926","603456","LU0871576103.HKD","HK0000306701.USD","LU2148510915.USD","HK0000306685.HKD","LU1051769294.HKD","002371","LU2488822045.USD","300274","IE00BMPRXN33.USD","605333","000921","BK0236","BK0187","02269","02273","600519","600436","LU0516423091.SGD","600276","600938","LU0594300179.USD","300502","LU1880383366.USD","600085","601127","002475","300759","BK0028","LU0456827905.SGD","SG9999001093.SGD","LU0531971595.HKD","BK1219","LU0880133367.SGD","000999","000423","000568","300347","LU0577902371.SGD","LU0359202008.SGD","300015","LU1781817850.SGD","300308","LU0327786744.USD"],"gpt_icon":0},{"id":"2451688056","title":"北向资金7月12日净买入九洲药业14.47万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2451688056","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451688056?lang=zh_cn&edition=full","pubTime":"2024-07-15 09:30","pubTimestamp":1721007033,"startTime":"0","endTime":"0","summary":"7月12日, 北向资金增持九洲药业14.47万股，连续3日增持。截止当日收盘，沪股通共持有九洲药业994.48万股，占流通股1.10%。沪股通增持金额前五个股分别为招商银行、中远海控、澜起科技、中国平安、工商银行。九洲药业近5个交易日上涨1.78%，沪股通累计增持166.28万股；近20个交易日下跌8.49%，沪股通累计增持148.02万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071509343695bd3560&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071509343695bd3560&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","603456","BK0239"],"gpt_icon":0},{"id":"2450846153","title":"九洲药业07月11日主力资金流出342万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2450846153","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450846153?lang=zh_cn&edition=full","pubTime":"2024-07-11 15:19","pubTimestamp":1720682362,"startTime":"0","endTime":"0","summary":"07月11日, 九洲药业股价涨5.17%，报收13.64元，成交金额2.11亿元，换手率1.74%，振幅4.16%，量比1.48。九洲药业今日主力资金净流出342万元，连续3日净流出，上一交易日主力净流出186万元，今日环比增加83.87%。该股近5个交易日上涨7.06%，主力资金累计净流入348万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出4566万元，其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407111533369f32d928&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407111533369f32d928&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0070","603456"],"gpt_icon":0},{"id":"2450777058","title":"九洲药业大幅上涨 获北向资金增持17.95万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2450777058","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450777058?lang=zh_cn&edition=full","pubTime":"2024-07-11 10:06","pubTimestamp":1720663601,"startTime":"0","endTime":"0","summary":"资金动向截止发稿，九洲药业获得主力净流出141万元，其中超大单流出115万元，大单流出25万元。北向资金方面，九洲药业07月10日获得北向资金增持17.95万股，截至07月10日，北向资金当前共持有九洲药业805.65万股，市值1.10亿元，持股占流通股比为0.89%。最新财报显示，今年一季报，九洲药业实现营业收入14.76亿元，同比减少15.73%，净利润为2.37亿元，同比减少15.65%，基本每股收益为0.26元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711100701aef919f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711100701aef919f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","BK0239","603456"],"gpt_icon":0},{"id":"2450405981","title":"CRO概念盘中跳水，九洲药业跌1.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450405981","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450405981?lang=zh_cn&edition=full","pubTime":"2024-07-09 10:08","pubTimestamp":1720490888,"startTime":"0","endTime":"0","summary":"07月09日，CRO概念盘中跳水，截至10点08分，CRO概念整体指数下跌2.06%，报311.660点。从个股上来看，该概念的成分股中，九洲药业跌1.47%，义翘神州、诚达药业、蔚蓝生物跌幅居前。从资金上来看，截止发稿，CRO概念主力净流入为-8164.84万，其中华测检测受到资金热捧，主力净流入424.33万；拉长时间线来看，该板块近20日主力资金净流入-37.80亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407091008089681ae46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407091008089681ae46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603456","BK0239","BK0070"],"gpt_icon":0},{"id":"2449775812","title":"九洲药业： 产品取得注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2449775812","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449775812?lang=zh_cn&edition=full","pubTime":"2024-07-08 18:50","pubTimestamp":1720435826,"startTime":"0","endTime":"0","summary":"每经AI快讯，九洲药业 7月8日晚间发布公告称，近日，浙江九洲药业股份有限公司控股子公司浙江九洲生物医药有限公司收到国家药品监督管理局核准签发的奥卡西平片的《药品注册证书》。2023年1至12月份，九洲药业的营业收入构成为：化学原料药及中间体的生产及销售占比97.87%。截至发稿，九洲药业市值为116亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407081850459f1e2f18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407081850459f1e2f18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603456","BK0070","BK0239"],"gpt_icon":0},{"id":"2449727206","title":"九洲药业：\n公司发展战略、经营计划详见2023年年度报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2449727206","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449727206?lang=zh_cn&edition=full","pubTime":"2024-07-08 18:04","pubTimestamp":1720433072,"startTime":"0","endTime":"0","summary":"证券之星消息，九洲药业07月08日在投资者关系平台上答复投资者关心的问题。九洲药业董秘：您好，感谢您对公司的关注与支持，公司发展战略、经营计划详见2023年年度报告。2020年公司与上海医药成立合资公司，拟从事原料药与高端制剂开发与生产。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070800025067.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","603456"],"gpt_icon":0},{"id":"2449726305","title":"九洲药业最新公告：控股子公司获得奥卡西平片的药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2449726305","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449726305?lang=zh_cn&edition=full","pubTime":"2024-07-08 16:31","pubTimestamp":1720427475,"startTime":"0","endTime":"0","summary":"九洲药业公告，控股子公司九洲生物近日收到国家药品监督管理局核准签发的奥卡西平片的《药品注册证书》。奥卡西平片用于治疗原发性全面性强直-阵挛发作和部分性发作，伴有或不伴有继发性全面性发作。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070800021107.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603456","BK0070"],"gpt_icon":0},{"id":"2449256377","title":"九洲药业(603456.SH)：奥卡西平片获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2449256377","media":"格隆汇资讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449256377?lang=zh_cn&edition=full","pubTime":"2024-07-08 16:27","pubTimestamp":1720427269,"startTime":"0","endTime":"0","summary":"格隆汇7月8日丨九洲药业(603456.SH)公布，控股子公司浙江九洲生物医药有限公司收到国家药品监督管理局核准签发的奥卡西平片的《药品注册证书》，奥卡西平片用于治疗原发性全面性强直-阵挛发作和部分性发作，伴有或不伴有继发性全面性发作。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407081628409f1d6fc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407081628409f1d6fc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603456","BK0239","BK0070"],"gpt_icon":0},{"id":"2449524928","title":"九洲药业（603456）7月5日主力资金净买入825.50万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449524928","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449524928?lang=zh_cn&edition=full","pubTime":"2024-07-06 08:12","pubTimestamp":1720224729,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月5日收盘，九洲药业报收于13.45元，上涨5.57%，换手率1.69%，成交量15.14万手，成交额1.98亿元。近5日资金流向一览见下表：九洲药业融资融券信息显示，融资方面，当日融资买入1666.31万元，融资偿还1493.81万元，融资净买入172.5万元。九洲药业主营业务：为国内外创新药公司及新药研发机构提供创新药在研发、生产方面的CDMO一站式服务,同时为全球客户提供化学原料药及医药中间体工艺技术创新和商业化生产的业务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070600012989.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603456","BK0070"],"gpt_icon":0},{"id":"2449263550","title":"九洲药业：\n公司具体股东人数请您参阅各期定期报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2449263550","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449263550?lang=zh_cn&edition=full","pubTime":"2024-07-05 19:03","pubTimestamp":1720177422,"startTime":"0","endTime":"0","summary":"投资者：瑞博正式投入生产能否给三季度带来可观的业绩九洲药业董秘：您好，感谢您对公司的关注与支持，三季度业绩情况请关注公司2024年三季报。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070500040663.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603456","BK0070","BK0239"],"gpt_icon":0},{"id":"2448541636","title":"XD九洲药07月04日遭主力抛售1622万元 环比增加168.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448541636","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448541636?lang=zh_cn&edition=full","pubTime":"2024-07-04 15:18","pubTimestamp":1720077503,"startTime":"0","endTime":"0","summary":"07月04日, XD九洲药股价跌2.00%，报收12.74元，成交金额1.15亿元，换手率0.99%，振幅3.38%，量比1.14。XD九洲药今日主力资金净流出1622万元，连续4日净流出，上一交易日主力净流出605万元，今日环比增加168.10%。|07月04日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|恒工精密|7.36%|#|雄帝科技|6.36%|#|C安乃达|5.12%|#|*ST中润|2.51%|#|湘邮科技|2.47%|#|优德精密|2.42%|#|雷赛智能|2.18%|#|盛通股份|2.16%|#|新时达|2.14%|#|大连热电|1.82%|XD九洲药所在的医疗服务行业，今日主力净流出4.80亿元，行业排名10/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407041528439f01990f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407041528439f01990f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603456","BK0070"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2014-10-10","address":"浙江省台州市椒江区外沙工业区","stockEarnings":[{"period":"1week","weight":-0.0298},{"period":"1month","weight":0.009},{"period":"3month","weight":-0.1412},{"period":"6month","weight":-0.2279},{"period":"1year","weight":-0.4682},{"period":"ytd","weight":-0.4282}],"companyName":"浙江九洲药业股份有限公司","boardCode":"AI0027","perCapita":"21239股","boardName":"医药制造业","registeredCapital":"89943万元","compareEarnings":[{"period":"1week","weight":-0.0244},{"period":"1month","weight":-0.0255},{"period":"3month","weight":-0.0686},{"period":"6month","weight":0.037},{"period":"1year","weight":-0.1172},{"period":"ytd","weight":-0.0279}],"survey":"　　浙江九洲药业股份有限公司主营业务为医药定制研发和生产（CDMO）服务，包含小分子化学药物、多肽药物、偶联药物和小核酸药物。公司产品涵盖合同定制类、抗感染类、中枢神经类药物、非甾体类药物、降血糖类药。公司获得中国医药工业百强企业、中国医药工业最具成长力企业、中国医药上市公司最具竞争力20强、第九届浙江省人民政府质量管理创新奖等多项荣誉。","serverTime":1722315589656,"listedPrice":15.43,"stockholders":"42285人(较上一季度增加9.45%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"九洲药业(603456)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供九洲药业(603456)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"九洲药业,603456,九洲药业股票,九洲药业股票老虎,九洲药业股票老虎国际,九洲药业行情,九洲药业股票行情,九洲药业股价,九洲药业股市,九洲药业股票价格,九洲药业股票交易,九洲药业股票购买,九洲药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"九洲药业(603456)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供九洲药业(603456)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}